首页 › 基金 › Flagship Pioneering, LLC › GENB
Flagship Pioneering, LLC 对 GENB 的持仓历史
GENERATE BIOMEDICINES INC · 医疗保健
Flagship Pioneering, LLC 在 Q2 2026 的 13F 申报中披露持有 GENB(GENERATE BIOMEDICINES INC)62,673,117 股,市值约 US$1.06B,约占其申报组合的 68.66%,在其申报持仓中市值排名第 1 位。 Flagship Pioneering, LLC 最近 2 个申报季度中有 2 个季度披露了 GENB 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Flagship Pioneering, LLC 对 GENB 的持仓演变
Flagship Pioneering, LLC 于 Q1 2026 首次披露 GENB 持仓:62,673,117 股(约 US$783.4M)。 该持仓在 Q2 2026 达到峰值 62,673,117 股,市值约 US$1.06B。 在 2 次申报中,Flagship Pioneering, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 62,673,117 股、市值约 US$1.06B。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 62.67M | $783.41M | 新进 |
| Q2 2026 | 62.67M | $1.06B | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GENB 与 13F 数据
GENB(GENERATE BIOMEDICINES INC)属于医疗保健行业。我们追踪的基金中还有 96 只申报持有 GENB,申报仓位最大的包括:BRAIDWELL LP (US$55.4M), ARCH Venture Management, LLC (US$32.8M), HARBOURVEST PARTNERS LLC (US$29.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GENB 的基金
- BRAIDWELL LP 3.28M 股 · $55.40M · Q2 2026
- ARCH Venture Management, LLC 1.94M 股 · $32.80M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.72M 股 · $29.05M · Q2 2026
- BANQUE PICTET & CIE SA 1.77M 股 · $26.63M · Q3 2026
- 哈佛大学管理公司 1.11M 股 · $18.74M · Q2 2026
- HARVARD MANAGEMENT CO INC 1.11M 股 · $18.74M · Q2 2026
- NVIDIA CORP 833.33K 股 · $14.06M · Q2 2026
- Davern Capital Partners, LP 824.68K 股 · $13.91M · Q2 2026
更多关于 Flagship Pioneering, LLC
常见问题
How long has Flagship Pioneering, LLC held GENB?
Flagship Pioneering, LLC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Flagship Pioneering, LLC's current position in GENB?
As of Q2 2026, Flagship Pioneering, LLC holds 62.67M shares of GENB (GENERATE BIOMEDICINES INC), valued at $1.06B, representing 68.66% of its reported portfolio and ranking #1.
Has Flagship Pioneering, LLC been buying or selling GENB?
In the latest 13F filing (Q2 2026), Flagship Pioneering, LLC held unchanged its position in GENB. The position peaked in Q2 2026 at 62.67M shares.
Which other funds hold GENB?
Other major institutional holders of GENB include BRAIDWELL LP, ARCH Venture Management, LLC, HARBOURVEST PARTNERS LLC, among 96 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.